Skip to main content
OpenTrials
Completed

NCT Number: NCT03425604

Role of Intrauterine Insemination in Patients With Endometriosis I-II

Intrauterine insemination (IUI) is an ART that provides good results in selected patients, improving their reproductive prognosis. Endometriosis I y II, according to ASRM classification, remains an indication to perform IUI. This indication is on continuous debate, considering that different studies have shown controversial results about it, due to the poor reproductive outcomes in this group of patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Endometriosis I-II

Age range

18 year–38 year

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

< 38 years old women, antral follicle count > 6, basal FSH < 10mUI/ml, BMI<30, Infertility time <4 years, absence of uterine malformations, endometrial polyps or myomas, absence of known thrombofilia, normal kayotype, < 3 previous IUI cycles, no male severe factor associated

-

Exclusion criteria

  • > 38 years old

Treatment and study plan

Intrauterine Insemination

Procedure

Primary outcomes

  1. pregnancy rate

    Time frame: 2011-2017

    to compare pregnancy rate between Endometriosis I-II patients (according to ASRM classification) vs. control group (patients without endometriosis) going under an IUI cycle

Sponsors and collaborators

Lead sponsor

IVI Bilbao

Other

Registry information

Important dates

Study start
2011
Primary completion
2017
Study completion
2017
First posted
Feb 7, 2018
Registry last updated
Feb 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.